Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference

Rhea-AI Summary

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) announced that President Joe Hayon will present at the H.C. Wainwright 24th Annual Global Investor Conference on September 12, 2022, at 7:00 a.m. ET. One-on-one meetings with Hayon will take place on September 13-14, 2022. Inspira Technologies is known for its innovative Augmented Respiration Technology, aimed at improving patient oxygen saturation without invasive procedures. The technology is not yet approved for human use. For further details, visit their Investor Relations page.

RA'ANANA, ISRAEL, Sept. 1, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, today announced that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the H.C. Wainwright 24th Annual Global Investor Conference on Monday, September 12, 2022.

The presentation will go live on Monday, September 12, 2022, at 7:00 a.m. ET. Joe Hayon will be available for one-on-one meetings on Tuesday and Wednesday, September 13-14, 2022. To schedule a meeting, please contact your H.C. Wainwright representative or Miri Segal at msegal@ms-ir.com.

For more information regarding these events, please visit Inspira Technologies' Investor Relations page here.

About Inspira Technologies OXY B.H.N. Ltd.

Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (Inspira™ART), designed to rebalance patient oxygen saturation levels. The Company's technology potentially allows patients to remain awake during treatment while minimizing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's product has not yet been tested or used in humans and has not been approved by any regulatory entity.

For more information, please visit our corporate website: www.inspirao2.com.

Copyright © 2018-2022 Inspira Technologies OXY B.H.N. LTD. All rights reserved.

Logo - https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg

For more details:
Miri Segal
Investor Relations, MS-IR LLC
+1-917-607-8654
msegal@ms-ir.com

View original content:https://www.prnewswire.com/news-releases/inspira-technologies-to-present-at-the-hc-wainwright-24th-annual-global-investor-conference-301616306.html

SOURCE Inspira Technologies

FAQ

When will Inspira Technologies present at the H.C. Wainwright conference?

Inspira Technologies will present on September 12, 2022, at 7:00 a.m. ET.

Who is presenting for Inspira Technologies at the investor conference?

Joe Hayon, President and Co-Founder, will present at the conference.

What is the focus of Inspira Technologies' presentation?

The presentation will focus on their innovative respiratory support technology, Inspira™ART.

When can investors schedule one-on-one meetings with Joe Hayon?

One-on-one meetings can be scheduled on September 13-14, 2022.

What is Inspira Technologies known for?

Inspira Technologies is known for its Augmented Respiration Technology aimed at improving oxygen saturation in patients.

Is Inspira Technologies' technology approved for human use?

No, the technology has not yet been tested or approved for human use.